Philippe De Grandpré
degrandpre-phil.bsky.social
Philippe De Grandpré
@degrandpre-phil.bsky.social
Pharmacien, intérêt pour la douleur chronique, Président de la Société québécoise de la douleur, amateur de plein air.
Il est plus que temps, il y a des options beaucoup plus sécuritaires pour les allergies et des stratégies beaucoup plus intéressantes comme la tcc-i pour le sommeil: mieux-dormir.ca #choisiravecsoins #choosingwisely
Le Benadryl et les Sleep-eze ne devraient plus être en vente libre, recommande-t-il.
Le Bureau du coroner souhaite voir la diphénhydramine retirée des tablettes
www.ledevoir.com
May 7, 2025 at 10:43 PM
Reposted by Philippe De Grandpré
Come chat with our clinical affairs director, @anaislacasse.bsky.social and executive director @mmebeaud.bsky.social to learn more about #pain research and management opportunities in Quebec and nationwide!
May 3, 2025 at 3:29 PM
Reposted by Philippe De Grandpré
Congratulations to our Early Career Award Winner, Dr. Gabrielle Pagé.
May 1, 2025 at 11:22 PM
Suivez moi dans les prochains jours, je publierai sur les moments forts du #canadianpain25
May 1, 2025 at 9:13 PM
Début du congrès de la Société canadienne de la douleur, c'est parti pour 4 jours d'apprentissage, d'échange et de réseautage pour mieux aider mes patients vivant avec de la douleur chronique.

Canadian pain society scientific meeting, it begins now #canadianpain25
May 1, 2025 at 9:12 PM
On se voit la semaine prochaine à Toronto.

See you next week in Toronto

#cps2025
The 2025 Annual Scientific Meeting is set to be the largest pain-centered gathering in Canada! 🍁

📅 Check out the full agenda and speaker lineup now!
🔗 Register today www.canadianpainsociety.ca/asm

#canadianpain25 #douleurcanadienne25
April 25, 2025 at 1:21 AM
Reposted by Philippe De Grandpré
Updated guidelines for the treatment of Neuropathic Pain just published in Lancet Neurology. It was quite the experience, and honor, to be involved in this project along with so many NeuPSIG colleagues. #PainResearch
www.sciencedirect.com/science/arti...
Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis
There remains a substantial unmet need for effective and safe treatments for neuropathic pain. The Neuropathic Pain Special Interest Group aimed to up…
www.sciencedirect.com
April 17, 2025 at 10:58 PM
Reposted by Philippe De Grandpré
New study shows PACAP38 can trigger migraines independently of CGRP. Blocking CGRP with eptinezumab didn’t prevent PACAP38-induced attacks — suggesting a new treatment pathway for migraine relief. Read more: doi.org/10.1186/s101... #headacheresearch #migraine
April 16, 2025 at 10:33 AM
Reposted by Philippe De Grandpré
Just made a video today about how to do more throughout the day, without increasing your pain, by following the 3P's
- Planning
- Prioritising
- Pacing

Let me know if you think it is useful. I always welcome feedback.

#SelfmgtLIVING-Works = paintoolkit.thinkific.com/
April 10, 2025 at 8:28 PM
Reposted by Philippe De Grandpré
🌟 Vivre avec la #DouleurChronique tout en maintenant une bonne qualité de vie, c’est possible pour 1 personne sur 3. Comment?

Notre infographie « Douleur : #DémystifionsLaScience » résume une étude sur les #ConditionsGagnantes pour y parvenir 🔍⬇️

#QualitéDeVie #RechercheDouleur
April 7, 2025 at 2:31 PM
Reposted by Philippe De Grandpré
Apprenez-en plus sur le rôle des pharmacien(ne)s dans la gestion de la douleur grâce à ce balado auquel @degrandpre-phil.bsky.social‬, pharmacien, membre du @rqrd-qprn.bsky.social et président de la Société québécoise de la douleur, a participé.

🎧 Écoutez ici 👇

zurl.co/NoCn1
Les pharmaciens, des alliés pour la gestion de la douleur
Parlons douleur · Episode
zurl.co
March 26, 2025 at 8:47 AM
Reposted by Philippe De Grandpré
🥼🎙️ Nouveau balado #ParlonsDouleur!

@iuliat.bsky.social échange avec @degrandpre-phil.bsky.social (pharmacien, membre RQRD, président SQD) sur le rôle des pharmacien.nes dans la gestion de la #douleur.

🎧 Écoutez ici 👉 zurl.co/NoCn1

@opq.org

#RQRD #SQD #Pharmacie #GestionDouleur
March 14, 2025 at 4:00 PM
Reposted by Philippe De Grandpré
🥼🎙️ New podcast #ParlonsDouleur!

@iuliat.bsky.social chats with @degrandpre-phil.bsky.social (pharmacist, RQRD member, SQD president) about the role of pharmacists in #pain management.

🎧 Listen here (in French) 👉 zurl.co/MB3OQ

@opq.org

#RQRD #SQD #Pharmacy #PainManagement
March 14, 2025 at 4:01 PM
Reposted by Philippe De Grandpré
Excellent visual from www.instagram.com/mindset.ther...

About the what Consistency is and looks like.

Pain supported self management also looks like this.

We included the importance of being CONSISTENT in the Pain Toolkit Academy - Online Course paintoolkit.thinkific.com

#SelfmgtLIVING-Works
March 8, 2025 at 7:41 AM
Reposted by Philippe De Grandpré
We're happy to share that our PEPR infographic is now available en français! Many thanks to our leadership team as well as @iuliat.bsky.social of @rqrd-qprn.bsky.social for the support.

#PeprPartnership #ChronicPain #patientengagement #DouleurChronique
March 6, 2025 at 8:39 PM
En quoi les coupes en recherche aux USA vont affecter la recherche en santé.
Studies show that funding from the National Institutes of Health (NIH) contributed to 354 of 356 drugs (99.4%) approved by the FDA from 2010 to 2019. Recklessly slashing NIH funding will mean that patients will be waiting much longer for life-saving treatments.
February 25, 2025 at 11:24 AM
Reposted by Philippe De Grandpré
🔟💊 Excessive polypharmacy is the concurrent use of 10+ medications. What are the different profiles of excessive polypharmacy among people living with chronic pain❓Is excessive polypharmacy a stable phenomenon over time❓
Check out our new paper📝 : bit.ly/4gP38sV
#ChronicPain #ChaireDouleurUQAT
Frontiers | Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study
bit.ly
February 21, 2025 at 11:21 AM
Reposted by Philippe De Grandpré
“Our study highlights the growing public health challenge posed by the combination of increasingly high-potency cannabis and rising regular cannabis use,” wrote #ICESOntario scientist Dr. Daniel Myran.
Read more: www.ctvnews.ca/toron...
Schizophrenia cases linked to cannabis use disorders nearly tripled over 17-year period: Ontario study
A new Ontario study has found “concerning increases” in the percentage of people diagnosed with schizophrenia after receiving care for cannabis use disorders.
www.ctvnews.ca
February 5, 2025 at 8:00 PM
Maintenant sur plus bluesky, je partage sur la douleur chronique et son traitement.

Now on bluesky, follow me for pain management science

Président de la Société québécoise de la douleur
January 28, 2025 at 11:16 AM